Keywords: Angel Biotechnology, Biologics market, Manufacturing capacity, Management team

UK’s Angel Biotech plans to increase manufacturing capacity, to capitalize on growing EU and US biologics markets

Article | 10 November 2010

UK biopharmaceutical contract manufacturer Angel Biotechnology Holdings (AIM: ABH) says that, in response to continuing demand for its products and ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Angel Biotechnology

Go to company listing